Welcome to the SANADII Trial Website
SANADII is a clinical trial designed to identify the most effective and cost-effective treatment for patients (adults and children over 5 years) with newly-diagnosed epilepsy.
The majority of the content of this website is aimed at patients and their families, but trial staff can access the randomisation website and other specific information via the ‘Researchers’ link on the left.
This trial is co-sponsored by the University of Liverpool and The Walton Centre for Neurology and Neurosurgery NHS foundation Trust, funded by the National Institute for Health Research Health Technology Assessment Programme (NIHR HTA) and coordinated by the Clinical Trials Research Centre – University of Liverpool.
SANAD II randomised its first patient on the 30th April 2013 at Alder Hey Children's Hospital and has now recruited 1510 participants from 94 opened sites.
View SANAD II Recruiting Centres in a full screen map
The University of Liverpool and the
Walton Centre are the co-sponsors for this study based in
the United Kingdom; they have delegated the day-to-day
management of the study to the Clinical Trials Research
Centre (CTRC), which is part of the University of Liverpool.
We will be using information from you and/or your medical
records in order to undertake this study and the University
of Liverpool and the Walton Centre will act as joint data
controllers for this study. This means that the University
of Liverpool and the Walton Centre are responsible for
looking after your information and using it properly. The
Walton Centre and the University of Liverpool will keep
identifiable information about you for 25 years after the
study has finished.
Your rights to access, change or move your information are
limited, as we need to manage your information in specific
ways in order for the research to be reliable and accurate.
To safeguard your rights, we will use the minimum
personally-identifiable information possible.
You can find out more about how we use your information in
the “How we use your
information” section on the Patient/Families
page.